Role of Aging and Individual Variation in Exercise Training Responsiveness

Not Applicable

Recruiting

• Conditions: Obesity; Prediabetic State; Cardiovascular Diseases; Insulin Resistance
• Interventions: Behavioral: High/Vig; Behavioral: Low/Mod; Behavioral: High/Mod

• Registration Number: NCT06471569
• Lead Sponsor: Duke University

Brief Summary

The primary purpose of this study is to assess the effects of aging on markers of physical reserve and exercise-induced adaptations in resilience in older adults who completed a structured exercise program within the last 15 years (Parent trial: STRRIDE-PD; NCT00962962). This feasibility pilot study will enroll up to 8 participants to complete a 6-month aerobic exercise intervention.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2024-06-10
• Study First Submitted QC: 2024-06-21
• Study First Posted: 2024-06-24
• Study Start: 2025-04-02
• Status Verified: 2025-05
• Last Update Submitted: 2025-05-08
• Last Update Posted: 2025-05-11
• Primary Completion: 2026-03-15
• Study Completion: 2026-03-15

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 8

Inclusion Criteria

• Individuals who completed participation in the STRRIDE-PD trial (NCT00962962)
• Body Mass Index (BMI) > 18 and < 45 kg/m2
• Stable dose (≥1 month) of any cardiometabolic medications

Exclusion Criteria

• Poor vein access
• Current use of tobacco or any nicotine products, including e-cigarettes
• Insulin-dependent diabetes
• Active untreated hyper or hypothyroidism with thyroid stimulating hormone (TSH) concentrations < 1.5 or > 10.0 uIU/mL
• Systemic inflammatory or connective tissue disease, chronic infectious disease, chronic pulmonary disease or symptomatic cardiovascular disease with positive functional study by ECG or imaging
• Current, actively treated malignancy other than dermatologic conditions
• Absolute contraindications to exercise testing: ongoing unstable angina; uncontrolled cardiac arrhythmia with hemodynamic compromise; active endocarditis; symptomatic severe aortic stenosis; decompensated heart failure; acute pulmonary embolism, pulmonary infarction, or deep vein thrombosis; acute myocarditis or pericarditis; acute aortic dissection; physical disability that precludes safe and adequate testing
• Relative contraindications to exercise testing: known obstructive left main coronary artery stenosis; moderate to severe aortic stenosis with uncertain relation to symptoms; tachyarrhythmias with uncontrolled ventricular rates; acquired advanced or complete heart block; hypertrophic obstructive cardiomyopathy with severe resting gradient; recent stroke or transient ischemic attack; mental impairment with limited ability to cooperate; uncorrected medical conditions, such as hypertension, significant anemia, important electrolyte imbalance, and hyperthyroidism
• Modified testing contraindications: acute myocardial infarction (MI) within six months; resting hypertension with systolic or diastolic blood pressures >160/90 mmHg
• Unable to safely participate in an exercise program per study protocol per PI discretion
• Planned, intentional weight loss during study

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
High Amount/Vigorous Intensity (High/Vig)	High/Vig	Six months of high amount/vigorous intensity aerobic exercise
Low Amount/Moderate Intensity (Low/Mod)	Low/Mod	Six months of low amount/moderate intensity aerobic exercise
High Amount/Moderate Intensity (High/Mod)	High/Mod	Six months of high amount/moderate intensity aerobic exercise

Primary Outcome Measures

Name	Time	Method
Cardiorespiratory Fitness	Baseline, early-intervention (~6 weeks), and post-intervention (~24 weeks)	Cardiorespiratory fitness will be measured with a maximal cardiopulmonary exercise test
Insulin Sensitivity	Baseline, early-intervention (~6 weeks), and post-intervention (~24 weeks)	Insulin sensitivity will be measured with a 2-hour oral glucose tolerance test

Secondary Outcome Measures

Name	Time	Method
Perceived Global Health	Baseline, early-intervention (~6 weeks), and post-intervention (~24 weeks)	Self-reported global health will be captured using the Patient-Reported Outcomes Measurement Information System (PROMIS). The questionnaire will be scored using "response pattern scoring" according to the PROMIS scoring manual in order to calculate the T-score for this outcome measure. The population mean T-score for global health is 50, with a score of 40 considered below average and a score of 60 considered above average.
Health-Related Quality of Life	Baseline, early-intervention (~6 weeks), and post-intervention (~24 weeks)	Health-related quality of life will be captured using the SF-36 Health Survey. The survey is scored into eight domains: physical functioning, role-physical, bodily pain, general health, vitality, social functioning, role-emotional, and mental health. Raw scores will be converted into scale scores ranging from 0 to 100, with higher scores representing better health-related quality of life.
Metabolic Syndrome Z-Score	Baseline, early-intervention (~6 weeks), and post-intervention (~24 weeks)	The metabolic syndrome z-score (MSSc) is a continuous weighted score of the five metabolic syndrome variables-fasting high-density lipoprotein cholesterol, triglycerides, glucose, waist circumference, and mean arterial blood pressure. A modified z-score will be calculated for each participant using continuous differences between the Adult Treatment Panel (ATP) III guideline values and participant values with normalization to the cohort's standard deviations. To account for variations in ATP III criteria between men and women, the investigators will use sex-specific MSSc equations. A lower MSSc indicates a better outcome.
Body Composition	Baseline and post-intervention (~24 weeks)	Body composition will be assessed as percent fat mass and percent fat-free mass.

Trial Locations

Locations (1)

Duke Center for Living; 🇺🇸 Durham, North Carolina, United States